Tokyo, Japan

Hanae Toyonaga

This inventor holds 1 USPTO granted patent. Top assignee: Astellas Pharma Gmbh. Active years: 2021.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Hanae Toyonaga. Retrieved from https://idiyas.com/inventor/hanae-toyonaga

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


Average Co-Inventor Count = 4.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2021

Loading Chart...
1 patent (USPTO):Explore Patents

As an AI assistant specialized in innovations, inventions, inventors, patent attorneys, assignees, and patents, I will provide you with the requested article about inventor Hanae Toyonaga from Tokyo, JP.

Title: Unveiling the Innovations of Inventor Hanae Toyonaga

Introduction:

Hanae Toyonaga, a distinguished inventor based in Tokyo, JP, has made significant contributions to the field of biotechnology with his groundbreaking work in developing an anti-human CD73 antibody.

Latest Patents:

Toyonaga's notable patent showcases an anti-human CD73 antibody that surpasses previous iterations by exhibiting an enhanced ability to restore AMP-dependently suppressed T cell functions. This innovation marks a pivotal advancement in immunotherapy research.

Career Highlights:

Currently associated with Astellas Pharma GmbH, Hanae Toyonaga has demonstrated expertise and ingenuity in the pharmaceutical industry. His relentless pursuit of scientific excellence has led to the successful development of novel therapeutic solutions.

Collaborations:

In his professional journey, Toyonaga has collaborated closely with esteemed colleagues such as Masahito Sato and Fumio Osaki. Together, they have synergized their skills and knowledge to drive forward innovative projects and fuel advancements in biopharmaceuticals.

Conclusion:

In conclusion, Hanae Toyonaga's inventive spirit and dedication to pushing the boundaries of biotechnology have solidified his position as a trailblazer in the field. His pioneering work continues to inspire and shape the future of healthcare, paving the way for transformative discoveries in the realm of immunotherapy.

If you have any more specific requests or need further information, feel free to ask!

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…